An open-label phase II study of the Hsp90 inhibitor ganetespib (STA-9090) as monotherapy in patients with advanced non-small cell lung cancer (NSCLC).

2011 ◽  
Vol 29 (15_suppl) ◽  
pp. 7500-7500 ◽  
Author(s):  
K. Wong ◽  
M. Koczywas ◽  
J. W. Goldman ◽  
E. H. Paschold ◽  
L. Horn ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Hsp90 Inhibitor ◽  
Small Cell ◽  
Small Cell Lung ◽  
Open Label ◽  
Open Label Phase

An open-label, phase II study of the polo-like kinase-1 (Plk-1) inhibitor, BI 2536, in patients with relapsed small cell lung cancer (SCLC)

Lung Cancer ◽  
2017 ◽  
Vol 104 ◽  
pp. 126-130 ◽  
Author(s):  
Mark M. Awad ◽  
Quincy S-C Chu ◽  
Leena Gandhi ◽  
Joe J. Stephenson ◽  
Ramaswamy Govindan ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
Open Label ◽  
Open Label Phase ◽  
Bi 2536
Sign in / Sign up

Export Citation Format

Share Document